Literature DB >> 22155108

A novel population of cells expressing both hematopoietic and mesenchymal markers is present in the normal adult bone marrow and is augmented in a murine model of marrow fibrosis.

Masanobu Ohishi1, Wanida Ono, Noriaki Ono, Richa Khatri, Marilena Marzia, Emma K Baker, Sierra H Root, Tremika Le-Shan Wilson, Yukihide Iwamoto, Henry M Kronenberg, Hector L Aguila, Louise E Purton, Ernestina Schipani.   

Abstract

Bone marrow (BM) fibrosis is a feature of severe hyperparathyroidism. Consistent with this observation, mice expressing constitutively active parathyroid hormone (PTH)/PTH-related peptide receptors (PPR) in osteoblasts (PPR*Tg) display BM fibrosis. To obtain insight into the nature of BM fibrosis in such a model, a double-mutant mouse expressing constitutively active PPR and green fluorescent protein (GFP) under the control of the type I collagen promoter (PPR*Tg/GFP) was generated. Confocal microscopy and flow cytometry revealed the presence of a cell population expressing GFP (GFP(+)) that was also positive for the hematopoietic marker CD45 in the BM of both PPR*Tg/GFP and control animals. This cell population was expanded in PPR*Tg/GFP. The existence of cells expressing both type I collagen and CD45 in the adult BM was confirmed by IHC and fluorescence-activated cell sorting. An analysis of total RNA extracted from sorted GFP(+)CD45(+) cells showed that these cells produced type I collagen and PTH/PTH-related peptide receptor and receptor activator for NF-κB mRNAs, further supporting their features of being both mesenchymal and hematopoietic lineages. Similar cells, known as fibrocytes, are also present in pathological fibroses. Our findings, thus, indicate that the BM is a permissive microenvironment for the differentiation of fibrocyte-like cells and raise the possibility that these cells could contribute to the pathogenesis of BM fibrosis.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155108      PMCID: PMC3349873          DOI: 10.1016/j.ajpath.2011.10.028

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation.

Authors:  Ian Rogers; Nobuko Yamanaka; Ryszard Bielecki; Christine J Wong; Shawn Chua; Shelia Yuen; Robert F Casper
Journal:  Exp Cell Res       Date:  2007-03-12       Impact factor: 3.905

Review 2.  Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.

Authors:  David J Kuter; Barbara Bain; Ghulam Mufti; Adam Bagg; Robert P Hasserjian
Journal:  Br J Haematol       Date:  2007-11       Impact factor: 6.998

Review 3.  Primary myelofibrosis.

Authors:  Ayalew Tefferi
Journal:  Cancer Treat Res       Date:  2008

4.  Pancytopenia and secondary myelofibrosis could be induced by primary hyperparathyroidism.

Authors:  D-J Lim; E J Oh; C-W Park; H-S Kwon; E-J Hong; K-H Yoon; M-I Kang; B-Y Cha; K-W Lee; H-Y Son; S-K Kang
Journal:  Int J Lab Hematol       Date:  2007-12       Impact factor: 2.877

5.  Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment.

Authors:  Benedetto Sacchetti; Alessia Funari; Stefano Michienzi; Silvia Di Cesare; Stefania Piersanti; Isabella Saggio; Enrico Tagliafico; Stefano Ferrari; Pamela Gehron Robey; Mara Riminucci; Paolo Bianco
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

6.  Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation.

Authors:  D C Lacey; P J Simmons; S E Graves; J A Hamilton
Journal:  Osteoarthritis Cartilage       Date:  2008-11-24       Impact factor: 6.576

Review 7.  Human circulating monocytes as multipotential progenitors.

Authors:  Noriyuki Seta; Masataka Kuwana
Journal:  Keio J Med       Date:  2007-06

8.  CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.

Authors:  Claudio Tripodo; Andrea Di Bernardo; Maria Paola Ternullo; Carla Guarnotta; Rossana Porcasi; Sabrina Ingrao; Umberto Gianelli; Emanuela Boveri; Emilio Iannitto; Giovanni Franco; Ada Maria Florena
Journal:  Haematologica       Date:  2008-11-23       Impact factor: 9.941

9.  Circulating osteogenic precursor cells in heterotopic bone formation.

Authors:  Robin K Suda; Paul C Billings; Kevin P Egan; Jung-Hoon Kim; Ruth McCarrick-Walmsley; David L Glaser; David L Porter; Eileen M Shore; Robert J Pignolo
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

10.  TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.

Authors:  Yi Tang; Xiangwei Wu; Weiqi Lei; Lijuan Pang; Chao Wan; Zhenqi Shi; Ling Zhao; Timothy R Nagy; Xinyu Peng; Junbo Hu; Xu Feng; Wim Van Hul; Mei Wan; Xu Cao
Journal:  Nat Med       Date:  2009-07-05       Impact factor: 53.440

View more
  10 in total

1.  An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen's Metaphyseal Chondrodysplasia.

Authors:  Hiroshi Noda; Jun Guo; Ashok Khatri; Thomas Dean; Monica Reyes; Michael Armanini; Daniel J Brooks; Janaina S Martins; Ernestina Schipani; Mary L Bouxsein; Marie B Demay; John T Potts; Harald Jüppner; Thomas J Gardella
Journal:  J Bone Miner Res       Date:  2019-12-04       Impact factor: 6.741

2.  Mesenchymal progenitors residing close to the bone surface are functionally distinct from those in the central bone marrow.

Authors:  Valerie A Siclari; Ji Zhu; Kentaro Akiyama; Fei Liu; Xianrong Zhang; Abhishek Chandra; Hyun-Duck Nah; Songtao Shi; Ling Qin
Journal:  Bone       Date:  2012-12-27       Impact factor: 4.398

3.  Connective Tissue Growth Factor reporter mice label a subpopulation of mesenchymal progenitor cells that reside in the trabecular bone region.

Authors:  Wen Wang; Sara Strecker; Yaling Liu; Liping Wang; Fayekah Assanah; Spenser Smith; Peter Maye
Journal:  Bone       Date:  2014-10-22       Impact factor: 4.398

Review 4.  Genetic tools for identifying and manipulating fibroblasts in the mouse.

Authors:  Jessica M Swonger; Jocelyn S Liu; Malina J Ivey; Michelle D Tallquist
Journal:  Differentiation       Date:  2016-06-21       Impact factor: 3.880

Review 5.  Visual reporters for study of the osteoblast lineage.

Authors:  Emilie Roeder; Brya G Matthews; Ivo Kalajzic
Journal:  Bone       Date:  2016-09-08       Impact factor: 4.398

6.  Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.

Authors:  Laura Mangiavini; Christophe Merceron; Elisa Araldi; Richa Khatri; Rita Gerard-O'Riley; Tremika L Wilson; George Sandusky; Jerome Abadie; Karen M Lyons; Amato J Giaccia; Ernestina Schipani
Journal:  Am J Pathol       Date:  2015-09-06       Impact factor: 4.307

7.  Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis.

Authors:  Srdan Verstovsek; Taghi Manshouri; Darrell Pilling; Carlos E Bueso-Ramos; Kate J Newberry; Sanja Prijic; Liza Knez; Ksenija Bozinovic; David M Harris; Erika L Spaeth; Sean M Post; Asha S Multani; Raajit K Rampal; Jihae Ahn; Ross L Levine; Chad J Creighton; Hagop M Kantarjian; Zeev Estrov
Journal:  J Exp Med       Date:  2016-08-01       Impact factor: 14.307

Review 8.  Fibrocytes: A Critical Review and Practical Guide.

Authors:  James W Reinhardt; Christopher K Breuer
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

9.  Effects of CreERT2, 4-OH Tamoxifen, and Gender on CFU-F Assays.

Authors:  Sophie L McHaffie; Nicholas D Hastie; You-Ying Chau
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

10.  Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics.

Authors:  Biancamaria Ricci; Eric Tycksen; Hamza Celik; Jad I Belle; Francesca Fontana; Roberto Civitelli; Roberta Faccio
Journal:  Elife       Date:  2020-08-05       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.